LeMaitre Vascular, Inc.

NasdaqGM:LMAT 주식 보고서

시가총액: US$2.4b

LeMaitre Vascular 관리

관리 기준 확인 4/4

LeMaitre Vascular CEO는 George LeMaitre, Jun1992 에 임명되었습니다 의 임기는 32.42 년입니다. 총 연간 보상은 $ 2.22M, 26.7% 로 구성됩니다. 26.7% 급여 및 73.3% 보너스(회사 주식 및 옵션 포함). 는 $ 202.06M 가치에 해당하는 회사 주식의 8.32% 직접 소유합니다. 202.06M. 경영진과 이사회의 평균 재임 기간은 각각 14.6 년과 19 년입니다.

주요 정보

George LeMaitre

최고 경영자

US$2.2m

총 보상

CEO 급여 비율26.7%
CEO 임기32.4yrs
CEO 소유권8.3%
경영진 평균 재임 기간14.6yrs
이사회 평균 재임 기간19yrs

최근 관리 업데이트

Recent updates

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 26% Price Boost Is Out Of Tune With Earnings

Nov 24
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 26% Price Boost Is Out Of Tune With Earnings

LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story

Nov 03

LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Nov 02
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?

Oct 08
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?

Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)

Sep 17
Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings

Sep 04
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings

If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity

Aug 22
If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity

LeMaitre Vascular: A Small Cap With Best-In-Industry Growth

Jul 23

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?

Jul 12
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?

Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Jun 18
Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing

Jun 05
Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear

May 02
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear

Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?

Apr 04
Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?

Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Feb 29
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Jan 19
What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture

Oct 27
Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture

Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Oct 11
Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?

Aug 30
Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?

The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence

Jul 06
The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?

May 20
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?

Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Mar 12
Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Oct 23
Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Oct 05
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital

Sep 13
LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital

LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers

Sep 08

LeMaitre Vascular goes ex dividend tomorrow

Aug 23

CEO 보상 분석

George LeMaitre 의 보수는 LeMaitre Vascular 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

US$41m

Jun 30 2024n/an/a

US$38m

Mar 31 2024n/an/a

US$34m

Dec 31 2023US$2mUS$593k

US$30m

Sep 30 2023n/an/a

US$27m

Jun 30 2023n/an/a

US$25m

Mar 31 2023n/an/a

US$21m

Dec 31 2022US$2mUS$568k

US$21m

Sep 30 2022n/an/a

US$21m

Jun 30 2022n/an/a

US$22m

Mar 31 2022n/an/a

US$27m

Dec 31 2021US$2mUS$473k

US$27m

Sep 30 2021n/an/a

US$28m

Jun 30 2021n/an/a

US$29m

Mar 31 2021n/an/a

US$24m

Dec 31 2020US$1mUS$311k

US$21m

Sep 30 2020n/an/a

US$19m

Jun 30 2020n/an/a

US$16m

Mar 31 2020n/an/a

US$18m

Dec 31 2019US$1mUS$438k

US$18m

Sep 30 2019n/an/a

US$19m

Jun 30 2019n/an/a

US$18m

Mar 31 2019n/an/a

US$23m

Dec 31 2018US$1mUS$438k

US$23m

Sep 30 2018n/an/a

US$21m

Jun 30 2018n/an/a

US$22m

Mar 31 2018n/an/a

US$18m

Dec 31 2017US$889kUS$162k

US$17m

보상 대 시장: George 의 총 보상 ($USD 2.22M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 6.56M ).

보상과 수익: George 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

George LeMaitre (59 yo)

32.4yrs

테뉴어

US$2,220,797

보상

Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...


리더십 팀

이름위치테뉴어보상소유권
George LeMaitre
Chairman & CEO32.4yrsUS$2.22m8.32%
$ 202.1m
David Roberts
President & Director17.3yrsUS$1.13m0.063%
$ 1.5m
Joseph Pellegrino
CFO, Secretary & Director17.3yrsUS$1.07m0.039%
$ 951.1k
Trent Kamke
Senior Vice President of Operations19.8yrsUS$670.38k0.0071%
$ 171.6k
George LeMaitre
Founder and Chairman of Scientific Advisory Board41.8yrsUS$138.40k데이터 없음
Kimberly Cieslak
Vice President of Marketing21.8yrs데이터 없음데이터 없음
Daniel Mumford
Senior Director of Human Resources4.8yrs데이터 없음데이터 없음
Jonathan Ngau
Senior Vice President of Information Technologyless than a year데이터 없음데이터 없음
Maik Helmers
Senior Vice President of Sales – Central Europeless than a year데이터 없음데이터 없음
Ryan Connelly
Senior Vice President of Advanced Manufacturing Engineering1.8yrs데이터 없음데이터 없음
Andrew Hodgkinson
Senior Vice President of Clinical11.8yrs데이터 없음데이터 없음
Stephane Maier
Senior Vice President of EMEA Operations4.1yrs데이터 없음데이터 없음

14.6yrs

평균 재임 기간

50.5yo

평균 연령

경험이 풍부한 관리: LMAT 의 관리팀은 노련하고 경험 (평균 재직 기간 14.6 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
George LeMaitre
Chairman & CEO32.4yrsUS$2.22m8.32%
$ 202.1m
David Roberts
President & Director23.5yrsUS$1.13m0.063%
$ 1.5m
Joseph Pellegrino
CFO, Secretary & Director8.1yrsUS$1.07m0.039%
$ 951.1k
George LeMaitre
Founder and Chairman of Scientific Advisory Boardno dataUS$138.40k데이터 없음
Lawrence Jasinski
Independent Director21.8yrsUS$153.50k0.019%
$ 454.4k
Thomas Naslund
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Steven Kagan
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Herbert Dardik
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Alan Dardik
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
William Jordan
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
John O'Connor
Independent Director16.2yrsUS$163.00k0.21%
$ 5.2m
Bridget Ross
Independent Director4.6yrsUS$144.50k0.0052%
$ 127.2k

19.0yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: LMAT 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 19 년).